Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors
Clinical trial NCT04975958 · COMPLETED
Trial details
- NCT number
- NCT04975958
- Sponsor
- Adlai Nortye Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-07
- Primary completion
- 2025-01-24
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.